|
|
|
|
|
|
By Mark F. Witcher, Ph.D., biopharma operations subject matter expert | Using relational risk analysis, let's take a closer look at risk management plans for identifying and managing adverse reactions for administering a new therapy to a patient. | |
|
|
| Roadmap To Successful Drug Therapy Partnerships | Video | Eurofins | Erik Jerks of Eurofins highlights advanced strategies for bioanalytical method development, showcasing case studies and technologies for bispecific antibodies and AAV-based drug assay challenges. |
|
|
|
| ThinkLive Cell and Gene Therapy Summit 2025 Summary | Article | Cencora | From patient support to intricate logistics, ThinkLive CGT Summit 2025 leaders tackled the essential commercial strategies needed to deliver these innovative therapies to patients globally. |
|
|
|
|
| Decoding The Human Immune System | Podcast | Biorasi | Michael Tolentino MD, Co-Founder and Head Scientific Consultant at Aviceda Therapeutics, discusses the power of glycol therapeutics in treating degenerative eye diseases. |
|
|
|
| Clinical Analytics Use Cases For AI | Video | Revvity Signals Software, Inc. | Automating FDA data validation rules and analyzing audit trail data can significantly reduce fraud and predict areas of concern. Discover how these advancements can transform your clinical trials. |
|
|
|
|
|
|
|
| Get ready for ISPE's largest event of the year, the 2025 ISPE Annual Meeting & Expo, 26–29 October, in Charlotte, North Carolina, USA, and virtually. This year's theme is Pharma 4.0™, with sessions exploring the integration of digitalization across all stages of pharmaceutical processes. Attendees can explore the latest advancements, network with like-minded professionals, and discover new technologies. Learn more and register |
|
|
CLINICAL TRIALS SOLUTIONS |
|
|
|
|
|
|
|
|
|
By Jennifer Chain, Ph.D., CABP, cellular starting material expert | In cell therapy development, the instinct to seek a single “best” option is natural — but in reality, there’s rarely a universal winner. | |
|
|
|
|
|
|
|
| Advancing the Future of Cell & Gene Therapy | This 11-12 November, Cell 2025 unites 1,000+ leading experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development timelines. Gain practical strategies across cell culture, therapy development, and CGT manufacturing, and hear from world-renowned leaders Bobby Gaspar (CEO, Orchard Therapeutics), Christof Von Kalle, (Director & BIH Chair, Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now |
|
|
Connect With Cell & Gene: |
|
|
|